Albany Molecular Research Inc. (AMRI) has signed a three-year collaborative agreement with biotechnology company HarkerBIO to co-market their drug discovery services to clients.
Galapagos has bolstered the portfolio of its BioFocus DPI contract services unit by purchasing the structure-based drug discovery business of UK firm Sareum.
In this week's round-up of activity within the preclinical research
services arena, news has emerged involving Exelgen, Epistem, Sareum
Holdings and WuXi PharmaTech.
Moscow, Russia-based Quantum Pharmaceuticals is offering
pharmaceutical and biotechnology companies the opportunity to test
the latest version of its molecular docking software - Quantum 2.0
- at no cost, reports Phil Taylor.
IBC is holding its 3rd international conference on Small Molecule
& Protein Structure-Based Drug Discovery by Design on 8-10
October 2003 in San Diego.
